E Maclay, D R Hadden, E M McIlrath, G S Nesbitt. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » AdolescentAdultAgedAnticonvulsants/adverse effectsAnticonvulsants/therapeutic useChildChild, PreschoolFemaleHumansHydroxycholecalciferols/bloodHyperparathyroidism, Secondary/chemically inducedHyperparathyroidism, Secondary/pathologyHypocalcemia/chemically inducedHypocalcemia/complicationsHypocalcemia/diagnostic imagingIntellectual Disability/drug therapyMaleMiddle AgedOsteomalacia/chemically inducedOsteoporosis/chemically inducedParathyroid Hormone/bloodPhenobarbital/administration & dosagePhenobarbital/adverse effectsPhenytoin/administration & dosagePhenytoin/adverse effectsPrimidone/administration & dosagePrimidone/adverse effectsRadiography
Substances: See more » AnticonvulsantsHydroxycholecalciferolsParathyroid HormonePrimidonePhenytoinPhenobarbital
Year: 1978 PMID: 653898 PMCID: PMC2385859
Source DB: PubMed Journal: Ulster Med J ISSN: 0041-6193